Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04408482 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Sep 1, 2024 to Sep 1, 2028v6
  2. 3 versions Re-verified since Feb 9, 2021, no change to tracked fieldsv3-v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jun 1, 2020 to Aug 1, 2020
    • Study sites: 0 to 1
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to compare the risk of PEP after pancreatic sphincterotomy performed for difficult cannulation in a group of patients with and in a group of patients without placement of a prophylactic pancreatic stent. The definition of difficult cannulation is defined according to the literature.
Trial Details
NCT Number NCT04408482
Lead Sponsor Helsinki University Central Hospital
Conditions
(from sponsor)		 Endoscopic Retrograde Cholangiopancreatography
Enrollment 268 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov